Literature DB >> 25126364

Review of strategies to enhance outcomes for patients with type 2 diabetes: payers' perspective.

Rhonda Greenapple1.   

Abstract

BACKGROUND: Diabetes and its clinical consequences exact a great toll on patients and on society in terms of its effects on morbidity and mortality and its staggering economic impact.
OBJECTIVE: To review various programs and strategies that aim at enhancing adherence to antihyperglycemic therapy and suggest the best approach to improving patient outcomes and reducing healthcare costs. DISCUSSION: Treatment goals for patients with diabetes have been defined, and multiple safe and effective medications are available. Nevertheless, the majority of patients with diabetes fail to achieve treatment goals, because of difficulty with adherence to medication regimens and lifestyle modifications, and because of economic barriers. This article discusses various initiatives developed to improve patient outcomes, including consumer-driven health plans and wellness and prevention programs. Furthermore, economic incentives to patients, such as value-based insurance design, may increase adherence; nevertheless, evidence suggests that such programs alone provide only modest gains. Primary providers in disease management programs can include nurses, case managers, or pharmacists. Supportive interventions across several modalities have been shown to be effective.
CONCLUSION: An approach that uses a combination of strategies designed to impact patients' health-related behaviors across a variety of modalities may help to improve outcomes and reduce costs. Additional novel, innovative interdisciplinary initiatives are necessary to effect meaningful change that can facilitate improved health outcomes for patients with diabetes and maximize cost-effectiveness approaches for payers.

Entities:  

Year:  2011        PMID: 25126364      PMCID: PMC4105736     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN: 1942-2962


  16 in total

1.  Diabetes disease management in Medicare Advantage reduces hospitalizations and costs.

Authors:  James L Rosenzweig; Michael S Taitel; Gordon K Norman; Tim J Moore; Wendy Turenne; Pei Tang
Journal:  Am J Manag Care       Date:  2010-07-01       Impact factor: 2.229

2.  Empowered physicians are key to diabetes program's success.

Authors:  Frank Diamond
Journal:  Manag Care       Date:  2009-01

3.  Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization.

Authors:  Kavita V Nair; Kerri Miller; Joseph Saseen; Pamela Wolfe; Richard Read Allen; Jinhee Park
Journal:  Am Health Drug Benefits       Date:  2009-01

4.  The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.

Authors:  Carole W Cranor; Barry A Bunting; Dale B Christensen
Journal:  J Am Pharm Assoc (Wash)       Date:  2003 Mar-Apr

5.  Novel therapeutics and targets for the treatment of diabetes.

Authors:  Thomas D Aicher; Steven A Boyd; Maralee McVean; Anthony Celeste
Journal:  Expert Rev Clin Pharmacol       Date:  2010-03       Impact factor: 5.045

6.  Diabetes Ten City Challenge: final economic and clinical results.

Authors:  Toni Fera; Benjamin M Bluml; William M Ellis
Journal:  J Am Pharm Assoc (2003)       Date:  2009 May-Jun

7.  The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.

Authors:  Barry A Bunting; Benjamin H Smith; Susan E Sutherland
Journal:  J Am Pharm Assoc (2003)       Date:  2008 Jan-Feb

8.  The impact of the highmark employee wellness programs on 4-year healthcare costs.

Authors:  Barbara L Naydeck; Janine A Pearson; Ronald J Ozminkowski; Brian T Day; Ron Z Goetzel
Journal:  J Occup Environ Med       Date:  2008-02       Impact factor: 2.162

9.  Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes: a preliminary report.

Authors:  Carol E Koro; Steven J Bowlin; Nancy Bourgeois; Donald O Fedder
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

10.  Web-based collaborative care for type 2 diabetes: a pilot randomized trial.

Authors:  James D Ralston; Irl B Hirsch; James Hoath; Mary Mullen; Allen Cheadle; Harold I Goldberg
Journal:  Diabetes Care       Date:  2008-11-18       Impact factor: 17.152

View more
  2 in total

1.  The illness experience of an undocumented immigrant in the USA.

Authors:  Jared G Blommel; Andres R Chacon; Stuart J Bagatell
Journal:  BMJ Case Rep       Date:  2018-10-14

Review 2.  A Systematic Review of Interventions Addressing Adherence to Anti-Diabetic Medications in Patients with Type 2 Diabetes--Components of Interventions.

Authors:  Sujata Sapkota; Jo-Anne E Brien; Jerry R Greenfield; Parisa Aslani
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.